Development of floating matrix tablets of Ofloxacin and Ornidazole in combined dosage form: in vitro and in vivo evaluation in healthy human volunteers
Keywords:
Ofloxacin. Ornidazole, Gastro retentive, Floating tablets, Hydroxy propyl methyl cellulose, Poly ethylene oxideAbstract
Ofloxacin (OFX) is a synthetic broad spectrum analog of second generation fluoroquinolone antibiotic. It is used for the treatment of urinary tract, prostate, skin, urinary and respiratory tract infections. Ornidazole (ORN) is a nitroimidazole derivative. It is used in the treatment of bacterial vaginosis, trichomoniasis, amoebiasis, giardiasis and infections due to anaerobic bacteria. These drugs are highly soluble in acidic media and precipitates in alkaline media thereby losing its solubility. Hence we attempted to develop a gastro retentive floating matrix type drug delivery system for Ofloxacin and Ornidazole in combined dosage form with hydroxyl propyl methyl cellulose (HPMC) K15M, HPMC K100M and polyethylene oxide 18NF (PEO). The physicochemical compatibility of the drug and the polymers was studied by infrared spectroscopy and differential scanning calorimetry. The results suggested no physicochemical incompatibility between the drug and the polymers. The prepared floating drug delivery systems were evaluated for physicochemical characteristics, mainly in vitro release and in vivo residence time by radiographic studies. The best formulation (F2) was selected based on in vitro release and physicochemical characteristics and used in vivo radiographic studies by incorporating BaSO4. These studies revealed that tablets 300 μ 30 minutes in healthy human volunteers in fasting state and indicated that the gastric retention was increased by floating principle. By fitting the data into zero order, first order and Higuchi models, it was concluded that drug release from matrix tablets followed Higuchi model and the mechanism of drug release was diffusion mediated. Based on the physical evaluation, in vitro drug release and in vivo characteristics, it was concluded that for potential therapeutic use, suitable for the development of a floating drug delivery system of Ofloxacin and Ornidazole in combined dosage form.
References
. S. Baumgartner, J. Kristl, F. Vrecer, P. Vodopivec and B. Zorko, Optimization of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000; 195: 125–135.
. Davis SS, Stockwel AF, Taylor MJ, Hardy JG, Whalley DR, Wilson CG. The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm. Res 1986; 3: 208–213.
. BN Sing and KH Kim. Floating drug delivery systems: an approach to oral controlled drug Delivery via gastric retention. J. Control. Rel. (2000); 20: 235–259.
. Ponchel G, Irache JM. Specific and nonspecific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv. Drug Del. Rev. 1998; 34:191–219.
. Akiyama Y, Nagahara N. Novel Formulation approaches to oral mucoadhesive drug delivery systems. Bioadhesive Drug Delivery Q6 Systems 1999; first ed: pp.357 477–506.
. A Rubinstein and DR Friend. Specific Delivery to the Gastrointestinal Tract, in Polymeric Site-Specific Pharmacotherapy 1994; pp. 283–285.
. Caldwell LJ, Gardner CR, Cargill RC. Drug delivery device which can be retained in the stomach for controlled period of time. US Patent 473 5804. April 5, 1988.
. Deshpande AA, Shah NH, Rhodes CT, Malick W. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm 1996; 22: 531–539.
. Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst 1998; 15: 243–284.
. Henry A, Okeri, and Ikhuorian MA. Analytical profile of the fluoroquinolone antibacterials. African Journal of Biotechnology 2008; 17(6): 670-680.
. Rosa M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 1994; 105:65-70.
. Viral F Patel and Natavarlal M Patel. Intra Gastric Floating Drug Delivery System of Cefuroxime Axetil: In Vitro Evaluation. AAPS Pharma SciTech 2006; 7(1): E1-E7.
. Mahesh Chavanpatil, Paris Jain, Sachin Chaudhari, Rajesh Shear and Pradeep Vavia. Development of sustained release gastro retentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. International Journal of Pharmaceutics 2005; 304: 178-184.
. Nagori BP, Shrivastava B, Sharma V and Rajput AS. Spectrophotometric method for simultaneous estimation of ofloxacin and ornidazole in tablet dosage form. Indian Drugs 2006; 43: 51-53.
. Bhusari KP and Chaple DR. Simultaneous Spectrophotometric Estimation of Ofloxacin and Ornidazole in Tablet Dosage Form. Asian J. Research Chem 2009; 2(1): 60-62.
. JW Moore and HH Flanner. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles, Pharm. Technol 1996; 20: 64–74.
. Gohel MC, Panchal MK, Jogani VV. Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS Pharm Sci Tech 200; 1: 45-50.
. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drug dispersed in solid matrices. J Pharm Sci 1963; 52:1145–1149.
. Korsmeyer RW, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 24: 25–35.
. NA Peppas. Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv 1985; 60: 110–111.
